Transit-1: Evaluation Of Transition From Inhaled Treprostinil To Oral Selexipag

被引:0
|
作者
Frost, A. [1 ]
Benza, R. L. [2 ]
Farber, H. [3 ]
Kim, N. H. [4 ]
Hartline, B. K. [5 ]
Pfister, T. [6 ]
Shiraga, Y. [6 ]
McLaughlin, V. [7 ]
机构
[1] Houston Methodist Lung Ctr, Houston, TX USA
[2] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[3] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA
[4] Univ Calif San Diego, Pulm & Crit Care Med, San Diego, CA 92103 USA
[5] Actel Pharmaceut US Inc, San Francisco, CA USA
[6] Actel Pharmaceut Ltd, Allschwil, Switzerland
[7] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A3977
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Transition from IV epoprostenol to oral treprostinil in a patient with group 1 pulmonary arterial hypertension
    Sarangarm, Preeyaporn
    Elwood, Kirsten
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2021, 78 (23) : 2110 - 2115
  • [42] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Kimmig, Lucas M.
    Liao, Chuanhong
    Bag, Remzi
    [J]. LUNG, 2020, 198 (01) : 53 - 58
  • [43] Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
    Lucas M. Kimmig
    Chuanhong Liao
    Remzi Bag
    [J]. Lung, 2020, 198 : 53 - 58
  • [44] Safety and Efficacy of Transition from Systemic Prostanoids to Inhaled Treprostinil in Pulmonary Arterial Hypertension
    Perez, Vinicio A. de Jesus
    Rosenzweig, Erica
    Rubin, Lewis J.
    Poch, David
    Bajwa, Abubakr
    Park, Myung
    Jain, Mohit
    Bourge, Robert C.
    Kudelko, Kristina
    Spiekerkoetter, Edda
    Liu, Juliana
    Hsi, Andrew
    Zamanian, Roham T.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (10): : 1546 - 1550
  • [45] Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus
    Saiki, Chihiro
    Kashiwado, Yusuke
    Yokoyama, Taku
    Ayano, Masahiro
    Imabayashi, Keisuke
    Kawano, Shotaro
    Higashioka, Kazuhiko
    Kimoto, Yasutaka
    Fukata, Mitsuhiro
    Mitoma, Hiroki
    Ono, Nobuyuki
    Arinobu, Yojiro
    Akashi, Koichi
    Horiuchi, Takahiko
    Niiro, Hiroaki
    [J]. MODERN RHEUMATOLOGY CASE REPORTS, 2022, 6 (02) : 183 - 188
  • [46] Clinical Improvement in Pulmonary Arterial Hypertension (PAH) Patients Transitioning from Selexipag to Oral Treprostinil: Interim Results from the ADAPT Registry
    Lachant, D.
    Minkin, R.
    Swisher, J.
    Mogri, M.
    Zolty, R.
    Shelton, D.
    Seaman, S.
    Broderick, M.
    Sahay, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [47] Rapid Initiation, Titration, and Transition from IV to Oral Treprostinil: A Retrospective Study
    Chin, J.
    Kaur, J.
    Mehta, J. P.
    Rahaghi, F. F.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] Right Heart Catheterization Further Confirms Successful Transition from Parenteral Prostanoid to Oral Selexipag
    Lazar Salvador, Maria
    Escribano Subias, Pilar
    Rodriguez Padial, Luis
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (07): : 393 - 394
  • [49] Real-World Transitions from Parenteral, Inhaled, and Oral Prostacyclin-Class Therapies to Oral Treprostinil: Interim Data from the ADAPT Registry
    Sahay, S.
    Ravichandran, A.
    Parikh, K.
    Gordon, K.
    Broderick, M.
    Lee, D.
    Swisher, J.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [50] Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension
    Keogh, Anne M.
    Jabbour, Andrew
    Weintraub, Robert
    Brown, Karen
    Hayward, Chris S.
    Macdonald, Peter S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (11): : 1079 - 1083